Cargando…
Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
BACKGROUND: Therapeutic outcome of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) can be modulated by thymidylate synthase (TS) levels, which may be altered by genetic polymorphisms in TS gene (TYMS). This study aims to elucidate the influence of TYMS polymorphisms in MTX therape...
Autores principales: | Lima, Aurea, Seabra, Vítor, Bernardes, Miguel, Azevedo, Rita, Sousa, Hugo, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184792/ https://www.ncbi.nlm.nih.gov/pubmed/25279663 http://dx.doi.org/10.1371/journal.pone.0108165 |
Ejemplares similares
-
Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid Arthritis Patients: Implication of MTHFR rs1801133 and ATIC rs4673993 Polymorphisms
por: Lima, Aurea, et al.
Publicado: (2014) -
Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
por: Lima, Aurea, et al.
Publicado: (2015) -
Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population
por: Lv, Shuang, et al.
Publicado: (2018) -
Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
por: López-Rodríguez, Rosario, et al.
Publicado: (2018) -
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
por: Owen, S A, et al.
Publicado: (2012)